ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

4-Methylmorpholine → (S)-4-(4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)-5-(benzyloxy)-5-oxopentanoic acid

HRID 1527654
印刷

反応式

HRID 1527654 の反応式
[NH2:1][C:2]1[NH:7][C:6]2[NH:8][CH:9]=[C:10]([CH2:11][CH2:12][C:13]3[CH:21]=[CH:20][C:16](C(O)=O)=[CH:15][CH:14]=3)[C:5]=2[C:4](=[O:22])[N:3]=1.CN1CCOCC1.ClC1N=[C:35]([O:37]C)[N:34]=C(OC)N=1.[CH:41]1[CH:46]=[CH:45][C:44]([CH2:47][O:48][C:49]([CH2:51][CH2:52][C@H:53](N)[C:54]([OH:56])=[O:55])=[O:50])=[CH:43][CH:42]=1>CN(C=O)C.O.C(Cl)Cl>[NH2:1][C:2]1[NH:3][C:4](=[O:22])[C:5]2[C:10]([CH2:11][CH2:12][C:13]3[CH:14]=[CH:15][C:16]([C:35]([NH:34][C@H:51]([C:49]([O:48][CH2:47][C:44]4[CH:45]=[CH:46][CH:41]=[CH:42][CH:43]=4)=[O:50])[CH2:52][CH2:53][C:54]([OH:56])=[O:55])=[O:37])=[CH:20][CH:21]=3)=[CH:9][NH:8][C:6]=2[N:7]=1
参加物反応条件実験手順後処理出典と根拠反応ノート

参加物

8

反応物 4

HCID 79724-MethylmorpholineHCID 184502-Chloro-4,6-dimethoxy-1,3,5-triazineHCID 122337L-Glutamic acid, 5-(phenylmethyl) esterHCID 178508847HCID 178508847、化合物

生成物 1

HCID 135544186(S)-4-(4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)-5-(benzyloxy)-5-oxopentanoic acid

試薬・触媒・溶媒 3

HCID 962Water溶媒HCID 6228Dimethylformamide溶媒HCID 6344Dichloromethane溶媒

反応条件

温度
25 °C

実験手順

To a solution of 4-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]-pyrimidin-5-yl)ethyl]benzoic acid (38.4 mg, 0.129 mmol) in 5 mL of DMF was added N-methylmorpholine (40.4 mg, 0.399 mmol), followed by the addition of 2-chloro-4,6-dimethoxy-1,3,5-triazine (22.64 mg, 0.129 mmol). The resulting mixture was stirred for 1.5 hours at 25° C., at which time HPLC showed that the reaction was complete. L-glutamic acid γ-benzyl ester (30.6 mg, 0.129 mmol) was added, and stirring was continued at 25° C. until complete conversion of precursor was determined by HPLC (around two hours). To the reaction mixture was added 10 mL of methylene chloride and 10 ml of deionized water, and the mixture was stirred for 15 minutes. The layers were separated. The aqueous layer was extracted with DCM (10 ml×2). The organic phases were combined. The solution was concentrated on rotary-evaporator under reduced pressure. The resulting residue was subjected to flash chromatography on a Biotage system. Yield: 55 mg, 82%. 1HNMR in d6-DMSO, δ ppm: 10.61 (1H, s), 10.20 (1H, s), 8.72 (1H, d, J=10 Hz), 7.78 (2H, d, J=5 Hz), 7.35 (5H, m), 7.30 (2H, m), 6.30 (1H, s), 6.07 (2H, s), 5.14 (2H, s), 3.86 (1H, m), 2.97 (2H, t), 2.84 (2H, t), 2.20 (2H, s), 2.02 (1H, m), 1.95 (1H, m). ESI-MS: 518 [M+H]+.

後処理

  1. stirringstirring
  2. customwas continued at 25° C. until complete conversion of precursor
  3. customwas determined by HPLC (around two hours)
  4. stirringthe mixture was stirred for 15 minutes
  5. customThe layers were separated
  6. extractionThe aqueous layer was extracted with DCM (10 ml×2)
  7. concentrationThe solution was concentrated on rotary-evaporator under reduced pressure

出典と根拠

ORDレコード
ord-991a51474d244ef08fc36aa1645e0d06
出典データセット
uspto-grants-2015_07
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US09089610B2

反応ノート

このページの内容参加物反応条件実験手順後処理出典と根拠反応ノート